Cynthia Melissa Valério

Author

Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione ORCID

Also Known As

C M Valerio, C Valerio, C. Valério, CYNTHIA M. VALERIO, Cynthia M Valerio, Cynthia M Valério, Cynthia M. Valerio, Cynthia Melissa Valerio, Cynthia Melissa Valério, Cynthia Melissai Valerio

Publications

Citations

H-Index

Concepts

All Affiliations

Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione Universidade Federal do Rio de Janeiro Universidade Federal de São Paulo Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Mossakowski Medical Research Institute, Polish Academy of Sciences

About

Cynthia Melissa Valério is an author at Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione specializing in metabolic syndrome, diabetes, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	5	6.9K
2	Diabetes	3	5	6.9K
3	Health Sciences	1	1	41
4	Public Health	1	2	5.6K
5	Global Health	1	1	41

Cynthia Melissa Valério

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations Patrícia B. Mory, Felipe Crispim, Maria Beatriz Sayeg Freire, European Journal of Endocrinology	2012	69
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation Iram Hussain, Nivedita Patni, Masako Ueda, The Journal of Clinical Endocrinology & Metabolism	2017	55
A New Method for Body Fat Evaluation, Body Adiposity Index, Is Useful in Women With Familial Partial Lipodystrophy Amélio F. Godoy‐Matos, Rodrigo O. Moreira, Cynthia Melissa Valério, Obesity NutritionMetabolic DisorderCardiometabolic RiskGynecologyWeight Management	2011	41
Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation Cynthia Melissa Valério, Lenita Zajdenverg, José Egídio Paulo de Oliveira, Diabetology & Metabolic Syndrome	2012	39
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) Rodrigo O. Moreira, Cynthia Melissa Valério, Cristiane Alves Villela‐Nogueira, Archives of Endocrinology and Metabolism	2023	26
Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2 Cynthia Melissa Valério, Juliana Severo de Almeida, Rodrigo O. Moreira, Diabetology & Metabolic Syndrome	2017	24
Dual-Energy X-Ray Absorptiometry Study of Body Composition in Patients With Lipodystrophy Cynthia Melissa Valério, Amélio F. Godoy‐Matos, Rodrigo O. Moreira, Diabetes Care	2007	23
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes Amélio F. Godoy‐Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, Diabetology & Metabolic Syndrome	2024	21

Page 1